Document:

a5466934ex10-2.htm

     Exhibit
      10.2

    

    AMENDMENTS
      TO EMPLOYMENT AGREEMENTS

    

    ARIAD
      Pharmaceuticals, Inc. (the “Company”) entered into an amendment to the
      employment agreement between the Company and each of the following executive
      officers, in April or May 2007, to extend the term of employment thereunder
      as
      follows:

     

    
      
        	 	 	
                Term
                  of Agreement Extended

              
	
                Name
                  and Title

              	 	
                From

              	
                To

              
	 	 	
                (December
                  31 of each year)

              
	
                Harvey
                  J. Berger, M.D.

                Chairman
                  and Chief Executive Officer

              	
                2009

              	
                2011

              
	
                Laurie
                  A. Allen, Esq.

                Senior
                  Vice President, Legal and Business Development,Chief Legal Officer
                  and
                  Secretary

              	
                2008

              	
                2010

              
	
                David
                  L. Berstein, Esq.

                Senior
                  Vice President, Chief Patent Counsel

              	
                2008

              	
                2010

              
	
                Timothy
                  P. Clackson, Ph.D.

                Senior
                  Vice President, Chief Scientific Officer

              	
                2008

              	
                2010

              
	
                Edward
                  M. Fitzgerald

                Senior
                  Vice President, Finance and Corporate Operations,Chief Financial
                  Officer
                  and Treasurer

              	
                2008

              	
                2010

              
	
                John
                  D. Iuliucci, Ph.D.

                Senior
                  Vice President, Chief Development Officer

              	
                2008

              	
                2010

              
	
                Richard
                  W. Pascoe

                Senior
                  Vice President, Chief Commercial Officer

              	
                2007

              	
                2010

              

      

    

     

    The
      term
      of employment for each officer is thereafter subject to automatic renewal for
      successive one-year terms (three-year terms in the case of Dr. Berger) absent
      notice to the contrary by either party.a5466934ex10-3.htm

    Exhibit
      10.3

    

    

    EXECUTIVE
      COMPENSATION ARRANGEMENTS

    

    Listed
      below are the base salaries for 2006 and 2007 for our named executive officers,
      and the performance awards and equity incentives in respect of performance
      for
      the eighteen-month period ended December 31, 2006 awarded to such
      officers.

     

    
      
        	 	 	
                2006

              	 	 
	 	 	 	 	 	 	
                Stock

              	 	
                Stock
                  Option

              	 	
                2007

              
	
                Executive
                  Officer

              	 	
                Salary

              	 	
                Bonus
                  (1)

              	 	
                Awards
                  (2)

              	 	
                Grants
                  (3)

              	 	
                Salary

              
	 	 	 	 	 	 	 	 	 	 	 
	
                Harvey
                  J. Berger, M.D.

              	 	
                $     544,000

              	 	
                --

              	 	
                $    296,960

              	 	
                240,000

              	 	
                $     576,000

              
	
                Chairman
                  of the Board, Chief Executive

                Officer
                  and
                  President

              	 	 	 	 	 	 	 	 	 	 
	
                David
                  L. Berstein, Esq.

              	 	
                $     309,000

              	 	
                $    167,000

              	 	
                --

              	 	
                60,000

              	 	
                $     329,000

              
	
                Senior
                  Vice President,

                Chief
                  Patent Counsel Chief Patent Counsel

              	 	 	 	 	 	 	 	 	 	 
	
                Timothy
                  P. Clackson, Ph.D.

              	 	
                $     309,000

              	 	
                $    185,000

              	 	
                --

              	 	
                57,500

              	 	
                $     333,000

              
	
                Senior
                  Vice President,

                Chief
                  Scientific Officer

              	 	 	 	 	 	 	 	 	 	 
	
                Edward
                  M. Fitzgerald

              	 	
                $     309,000

              	 	
                $    176,000

              	 	
                --

              	 	
                60,000

              	 	
                $     329,000

              
	
                Senior
                  Vice President,

                Finance
                  and Corporate Operations, Chief

                Financial
                  Officer and Treasurer

              	 	 	 	 	 	 	 	 	 	 
	
                John
                  D. Iuliucci, Ph.D.

              	 	
                $     309,000

              	 	
                $    167,000

              	 	
                --

              	 	
                70,000

              	 	
                $     329,000

              
	
                Senior
                  Vice President,

                Chief
                  Development Officer

              	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	 	 	 	 	 

      

    

     

    
      
        	
                (1)These
                  amounts
                  reflect deferred performance awards under our 2005 Executive Compensation
                  Plan granted in April 2007 in respect of performance for the period
                  from
                  July 1, 2005 to December 31, 2006.  These awards vest 24% on
                  each anniversary of the award date and will be payable in equal
                  installments on the fourth and fifth anniversaries of the grant
                  date,
                  subject to later payment at the executive’s direction.

              
	
                (2)This
                  award
                  was in the form of a grant of 64,000 sharesof common stock of the
                  Company,
                  under the Company’s 2006 Long Term Incentive Plan, which had a fair market
                  value based on the closing price of the Company’s stock on the date of
                  grant of $296,960.

              
	
                (3)Stock
                  options, except the stock options for Dr. Berger, were granted
                  on April
                  16, 2007, have an exercise price of $4.49 per share, which was
                  the fair
                  market value of our common stock on the date of grant, and vest
                  25% per
                  year over four years.  Dr. Berger’s stock options were granted
                  on March 6, 2007, have an exercise price of $4.64 per share, which
                  was the
                  fair market value of our common stock on the date of grant, and
                  vest 25%
                  per year over four years.  All stock option grants were made
                  under the Company’s 2006 Long Term Incentive Plan.a5467918ex10-4.htm

    Exhibit
      10.4

     

    RETIREMENT
      AND BOARD SERVICE ABOARD SERVICE AGREEMENT

     

    This
      Retirement and Board Service Agreement (the “Agreement”)
      dated as of June 26, 2007, is made by and between ANTs software
      inc., a Delaware corporation (the “Company”) and Francis K.
      Ruotolo (“Executive”).  Its purpose is to set forth the
      parties’ agreement regarding the cessation of employment status of the Executive
      with the Company, the continuation of the Executive’s service on the Company’s
      Board of directors, the mutual termination of the Executive’s Employment
      Agreement with the Company dated on March 23, 2007, the provision of the
      benefits Executive is to receive, and the provision of the mutual waivers and
      releases the parties are giving each other.

     

    Whereas,
      both parties agree and acknowledge receipt of sufficient consideration for
      the
      mutual promises and undertakings contained in this Agreement;

     

    The
      parties agree as follows:

     

    1.  Retirement.  Executive
      understands and agrees that he is retiring as an employee of the Company
      effective as of June 26, 2007.  That certain Employment Agreement
      dated March 23, 2007 by and between the Executive and the Company is hereby
      mutually terminated.

     

    2.  Continuation
      of Board Service.  Executive shall continue as a member
      of the Company’s Board of directors and shall continue as Chairman of the Board
      of directors of the Company.  In addition to the retirement benefits
      set forth below, the Company will pay to Executive non-executive Chairman board
      fees of $25,000 per annum.

     

    3.  Retirement
      Benefits.  In consideration for the releases provided
      herein and subject to the waiting period and other requirements set forth in
      paragraph 7, below, the Company shall pay Executive, as retirement benefits
      and
      on a 1099 basis, ten equal quarterly payments of fifty thousand dollars
      ($50,000) each, for an aggregate amount of Five Hundred Thousand dollars
      ($500,000), with the first such payment due on July 1, 2007 and the remaining
      payments paid in quarterly installments on October 1, January 1, April 1, and
      July 1 for each succeeding quarter until paid in full.  Company shall
      deposit $500,000 into a mutually agreeable escrow for such funds to be held
      in
      trust, to be paid out as required hereby.  The escrow agent shall be
      selected by Executive and the escrow shall be structured in such a manner that
      (i) it may not be revoked by the Company, and (ii) the funds deposited into
      the
      account shall not be considered part of the Company’s general funds, and shall
      be beyond the reach of the Company’s creditors.  All interest on such
      trust funds shall accrue to the benefit of Executive and be paid out with the
      final payment made.  All of Executive’s stock options shall be and
      continue unaffected by this Agreement.  The Company acknowledges and
      agrees that all of Executive’s stock options are fully vested and that such
      options shall be exercisable up to that date which is three months following
      cessation of Executive’s service on the Company’s Board of
      directors.  Company will provide to Executive, continuation health
      coverage pursuant to the Consolidated Omnibus Budget Reconciliation Act of
      1985
      (COBRA) for a period of eighteen months and at Executive’s cost.

     

    4.  General
      Mutual Release.  In exchange for the
      consideration provided in this Agreement, the adequacy of which is hereby
      acknowledged, each party hereto, on behalf of himself or itself and his or
      its
      heirs, successors and assigns, hereby fully releases and forever discharges
      the
      other party hereto, including each of their officers, directors, agents,
      employees, attorneys, parents, affiliates and/or subsidiaries, from any and
      all
      claims, actions and liabilities of any kind or character whatsoever, arising
      in
      law or in equity, known or unknown, suspected or unsuspected, that such party
      has ever had, now has or may now have against the other party, including,
      without limitation, all claims directly or indirectly related to or arising
      out
      of Executive’s employment by the Company, the performance of his duties during
      that employment, and/or the termination of or his resignation from that
      employment.  This waiver and release specifically includes, but is not
      limited to, all claims, if any, whether arising in tort or in contract, related
      to Executive’s employment, including any and all claims for wrongful discharge
      or wrongful termination; claims for alleged violation of public policy or breach
      of implied covenant of good faith and fair dealing; claims for breach of
      fiduciary duty; claims for negligent or intentional infliction of emotional
      distress; claims arising in connection with Executive’s compensation, benefits,
      warrants and/or stock options; claims for breach of express or implied contract
      or for further monetary compensation by way of additional salary or bonus
      allegedly due Executive by reason of his employment with the Company; and all
      other claims, based on common law or federal or state statute, including claims
      for discrimination based on age arising under state statute or the federal
      Age
      Discrimination in Employment Act, the Older Workers’ Benefits Protection Act, or
      any similar federal or state law prohibiting age discrimination.

     

     

    
      
        
        

      

      
        -1-

        
          

        

      

      
        
        

      

    

     

    Each
      party
      further understands and expressly agrees that this Agreement specifically
      extends to all claims, whether those claims are presently known to the party
      or
      not, or suspected by the party or not.  By signing below, each party
      expressly waives the benefits of Section 1542 of the California Civil Code,
      which provides:

     

    “A
      general release does not extend to claims which the creditor does not know
      or
      suspect to exist in his favor at the time of executing the release which if
      known by him must have materially affected his settlement with the
      debtor.”

     

    Executive
      agrees that he has not assigned or transferred, in whole or in part, any of
      the
      claims, actions or liabilities released by him herein.

     

    5.  No
      Admission of Liability.  The parties deny that either one
      of them has any liability to the other.  Neither this Agreement, nor
      the consideration the parties are receiving under it, shall be deemed or
      construed as an admission of liability by any party.

     

    6.  Confidentiality.  Each
      party agrees that the terms and conditions of this Agreement are and shall
      remain strictly confidential, and that none of them, nor anyone acting on his
      or
      its behalf, will disclose those terms and conditions to any third
      party:  (i) except that the Company may disclose the general terms as
      required under securities laws, (ii) except for Executive’s tax or legal
      advisors or his spouse, or (iii) unless compelled by law to do so.

     

    7.  Waiting
      Period.  Executive acknowledges that the Company
      has specifically advised him to consult with an attorney of his own choosing
      in
      order to review this Agreement and advise him of his rights concerning
      it.  Executive further acknowledges that the Company has further
      advised him that he has twenty-one (21) days from the date this Agreement was
      originally presented to him in which to consider whether to sign it, and that
      if
      he chooses to do so, he will be given an additional seven (7) days from the
      date
      he signs it in which to revoke it.  Unless revoked by Executive, this
      Agreement shall become effective the day immediately after the expiration of
      the
      seven (7) day period set forth above (the “Effective
      Date”).  Executive understands and agrees that this Agreement will not
      become effective before the Effective Date.  The offer contained in
      this Agreement will expire and may not be accepted by Executive following the
      expiration of twenty-one (21) days after this Agreement was first presented
      to
      him.

     

     

    
      
        
        

      

      
        -2-

        
          

        

      

      
        
        

      

       

    

    8.  Indemnification.  Each
      party shall indemnify, defend and hold harmless the other and his or its
      assignees against, and in respect of, any and all claims, demands, losses,
      costs, expenses, obligations, liabilities, damages, recoveries and deficiencies,
      including interest, penalties and reasonable attorneys’ fees (collectively
“Losses”) that the other or he or its assignees may incur which arise, result
      from or relate to any breach or failure by such party to perform any of such
      party’s covenants contained in this Agreement.

     

    9.  Voluntary
      Agreement.  Executive expressly acknowledges and warrants
      that he has read and fully understands this Agreement; that he has had the
      opportunity to consult with legal counsel of his own choosing in order to have
      the terms and conditions of this Agreement fully explained to him; that he
      is
      not executing this Agreement in reliance on any promises, representations or
      inducements other than those set forth herein; that he understands he is giving
      up legal rights by signing this Agreement; and that he is executing it
      voluntarily, free of any duress or coercion, after due deliberation, with a
      full
      understanding of what it means to do so.

     

    10.  Other
      Provisions.

    

    10.1  Binding
      Effect.  This Agreement shall be binding upon and inure to the
      benefit of the respective heirs, executors, representatives, successors and
      assigns of the parties hereto.

     

    10.2  Further
      Assurances.  The parties shall execute and deliver such
      instruments and take such other actions as may be reasonably necessary in order
      to carry out the intent of this Agreement.

     

    10.3  Counterparts.  This
      Agreement may be executed in any number of separate counterparts, each of which
      shall be deemed to be an original and all of which together shall be deemed
      to
      be one and the same instrument.

     

    10.4  Headings.  The
      subject headings of the sections and subsections of this Agreement are included
      for purposes of convenience only and shall not affect the construction or
      interpretation of any of its provisions.

     

    10.5  Waivers.  Any
      party to this Agreement may waive any right it may have hereunder or any breach
      or default hereunder by any other party hereto; provided that no such waiver
      will be effective against the waiving party unless it is in writing and
      specifically refers to this Agreement.  No waiver will be deemed to be
      a waiver of any subsequent or other right, breach or default of the same or
      similar nature.

     

    10.6  Entire
      Agreement.  This Agreement, including the documents and things
      anticipated to be delivered hereby embodies the entire agreement and
      understanding of the parties hereto with respect to the subject matter hereof,
      and supersedes all prior or contemporaneous agreements or understandings
      (whether written or oral) among the parties, in respect to the subject matter
      contained herein.  This Agreement may not be modified, amended or
      terminated except by written agreement signed by both parties specifically
      referring to this Agreement.

     

     

    
      
        
        

      

      
        -3-

        
          

        

      

      
        
        

      

    

     

    10.7  Governing
      Law.  This Agreement is deemed to have been made in the State of
      California and shall be governed by, and construed in accordance with, the
      laws
      of the State of California for contracts made and to be performed within
      California.

     

    10.8  Assignment.  Executive
      may not assign this Agreement, or assign his rights or delegate his duties
      hereunder, without the prior written consent of the Company.

     

    10.9  Severability.  Any
      provision of this Agreement which is illegal, invalid or unenforceable shall
      be
      ineffective to the extent of such illegality, invalidity or unenforceability,
      without affecting in any way the remaining provisions hereof.

     

    10.10  No
      Rules of Construction.  No rules of construction are intended by
      the parties hereto or shall be invoked in the interpretation hereof and, for
      all
      purposes, the parties hereto shall all be deemed to be joint authors
      hereof.

     

    10.11  Notices.  All
      notices, demands and other communications provided for hereunder shall, unless
      otherwise stated herein, be in writing and shall be personally delivered or
      sent
      by nationally recognized overnight courier, with delivery
      acknowledged.

     

    10.12  Remedies.  The
      remedies herein provided are cumulative and not exclusive of any remedies
      provided by law.  The party against whom enforcement is sought shall
      pay on demand all losses, costs and expenses, if any, of the party seeking
      enforcement (including attorneys’ and other professionals' fees actually
      incurred) in connection with the enforcement of this Agreement.

    

    IN
      WITNESS WHEREOF,
      the parties hereto have caused this Agreement to be executed by their respective
      officers or representatives thereunto duly authorized, this Agreement to become
      effective as of the date first above written.

     

     

    
      	 	
              ANTS
                SOFTWARE INC.

              a
                Delaware Corporation

            	 
	 	 	 	 
	
               

            	
              
                By:

              

            	/s/
              Joe Kozak	 
	 	 	
              Joe
                Kozak, Chief Executive Officer

            	 

    

     

    

    
      	 	 	 	 
	
               

            	
               

            	/s/
              Francis K. Ruotolo	 
	 	 	
              Francis
                K. Ruotolo

            	 

    

    
 

    -4-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00127-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00127-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00127-of-00352.parquet"}]]